Post-COVID Opsoclonus Myoclonus Syndrome: A Case Report From Pakistan
TLDR
In this paper, a COVID-19 case manifesting as opsoclonus-myoclus syndrome (OMS), a rare neurological disorder, was presented, which was successfully treated with intravenous immunoglobulin (IVIG) with complete resolution of symptoms within 4 weeks of treatment.Abstract:
Background: Coronavirus disease-2019 (COVID-19), caused by the severe acute respiratory distress syndrome-coronavirus-2 (SARS-CoV-2), is primarily a respiratory infection but has been recently associated with a variety of neurological symptoms. We present herewith a COVID-19 case manifesting as opsoclonus-myoclonus syndrome (OMS), a rare neurological disorder. Case Presentation: A 63-year-old male diagnosed with COVID-19 infection developed behavioral changes, confusion, and insomnia followed by reduced mobility and abnormal eye movements within 48 h of recovery from respiratory symptoms associated with COVID-19. On examination, he had rapid, chaotic, involuntary saccadic, multidirectional eye movements (opsoclonus), and limb myoclonus together with truncal ataxia. CSF analysis, MRI of the brain, and screening for anti-neuronal and encephalitis related antibodies were negative. Extensive testing revealed no underlying malignancy. The patient was successfully treated with intravenous immunoglobulin (IVIG) with complete resolution of symptoms within 4 weeks of treatment. Conclusion: COVID-19 infection can be associated with the manifestation of opsoclonus myoclonus syndrome, a rare neurological disorder that can be treated with IVIG if not responsive to corticosteroids.read more
Citations
More filters
Journal ArticleDOI
Post COVID-19 neurological complications; a meta-analysis
Jaafar O. Ahmed,Shwan A. Ahmad,Marwan N. Hassan,Fahmi H. Kakamad,Rawezh Q. Salih,Berwn A. Abdulla,Fattah Hama Rahim Fattah,Shvan H. Mohammed,Razhan K. Ali,Abdulwahid M. Salih +9 more
TL;DR: The authors in this paper presented a quantitative meta-analysis of published studies regarding the post-infectious neurological complications of COVID-19, which revealed 60 cases -of which 40 (66.7%) cases were male, and 18 (30%) were female.
Journal ArticleDOI
AI-CoV Study: Autoimmune Encephalitis Associated With COVID-19 and Its Vaccines—A Systematic Review
M. Samim,Debjyoti Dhar,Sheetal Goyal,Treshita Dey,Nazni Parvin,Rutu Shah,A. K. Singh,Sampurna Chowdhury,Bhavesh Mohan Lal,Nibu Varghese,Abhishek Gohel,Abhishek Chowdhury,Aritra Chatterjee,S. Siddiqui +13 more
TL;DR: In this article , the authors aim to systematically review the clinico-investigational and pathophysiologic aspects of COVID-19 and its vaccines in association with AIE, and identify the factors predicting neurological severity and outcomes.
Journal ArticleDOI
Efferent neuro-ophthalmic complications of coronavirus disease 2019
TL;DR: In this article , the authors describe efferent neuro-ophthalmological complications that have been reported in association with coronavirus disease 2019 (COVID-19) infection and elaborate on mechanisms of disease, including para-infectious inflammation, hypercoagulability, endothelial damage, and direct neurotropic viral invasion.
Journal ArticleDOI
Opsoclonus Myoclonus Ataxia Syndrome Due to SARS-CoV-2
Josef Finsterer,Fulvio A. Scorza +1 more
TL;DR: In this article , a narrative review aims at summarising and discussing current knowledge about the clinical presentation, diagnosis, treatment and outcome of SARS-CoV-2 associated OMS/OMAS.
Journal ArticleDOI
Brain stem encephalitis is a rare complication of COVID-19
TL;DR: In this paper , the clinical phenotype of SARS-CoV-2-related CNS disease was described and evaluated using an antibody index as a tool to differentiate between a direct (viral) and indirect etiology.
References
More filters
Journal ArticleDOI
Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus–myoclonus
TL;DR: It is concluded that idiopathic OMS occurs in younger patients, the clinical evolution is more benign and the effect of immunotherapy appears more effective than in paraneoplastic OMS.
Journal ArticleDOI
Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004
Katherine K. Matthay,Franz Blaes,Barbara Hero,Dominique Plantaz,Pedro A. de Alarcon,Wendy G. Mitchell,Michael Pike,Vito Pistoia +7 more
TL;DR: This paper summarizes the results obtained at the 2004 Advances in Neuroblastoma Research meeting, providing status of the art information on immune pathogenesis, clinical features, acute and chronic neurologic manifestations, current and novel therapeutic approaches.
Journal ArticleDOI
Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.
Thaís Armangue,Lidia Sabater,Estefanía Torres-Vega,Eugenia Martinez-Hernandez,Helena Ariño,Mar Petit-Pedrol,Jesús Planagumà,Luis Bataller,Josep Dalmau,Josep Dalmau,Josep Dalmau,Francesc Graus +11 more
TL;DR: The clinical and immunological features of idiopathic OMS (I-OMS) and paraneoplastic OMS, the occurrence of antibodies to cell surface antigens, and the discovery of a novel cell surface epitope are reported.
Journal ArticleDOI
Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues.
TL;DR: In this article, the authors studied the neural antigenic targets of serum IgM and IgG autoantibodies from nine children with OPSO-myoclonus (OM) and found that all nine children had IgM binding to the cytoplasm of cerebellar Purkinje cells and to some axons in white matter.
Journal ArticleDOI
Long-term follow-up of neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome.
E. De Grandis,Stefano Parodi,Massimo Conte,P. Angelini,F. M. Battaglia,Carlo Gandolfo,A. Pessagno,Vito Pistoia,Wendy G. Mitchell,Michael Pike,Riccardo Haupt,Edvige Veneselli +11 more
TL;DR: The results support the role of an early diagnosis of OMA in reducing sequelae and encourage the use of new immunosuppressive therapies.
Related Papers (5)
Opsoclonus myoclonus ataxia syndrome in severe acute respiratory syndrome coronavirus-2.
João Fernandes,Peter Puhlmann +1 more